Examples of using Prograf in English and their translations into Dutch
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
Treatment emergent fatal adverse events occurred in 1.2% of Envarsus patients and 0.6% of Prograf patients.
Patients were either switched to treatment with Envarsus once daily or continued Prograf treatment twice daily.
The dose recommendations for lung, pancreas and intestinal transplantation are based on limited prospective clinical trial data with the Prograf formulation.
safety of Envarsus and Prograf, both in combination with mycophenolate mofetil(MMF)
tacrolimus immediate-release capsules Prograf.
Prograf and associated names(see Annex I) 0.5 mg hard capsules Prograf and associated names(see Annex I) 1 mg hard capsules Prograf and associated names(see Annex I)
tacrolimus immediate-release capsules Prograf.
safety of Advagraf and Prograf, both in combination with mycophenolate mofetil(MMF)
Stable allograft recipients maintained on Modigraf granules, requiring conversion to Prograf capsules, should be converted on a 1:1 mg:
safety of Advagraf and Prograf, both in combination with corticosteroids,
following conversion between Modigraf granules to Prograf capsules, dose adjustments,
Dose recommendations- Conversion of Prograf treated patients to Advagraf Allograft transplant patients maintained on twice daily Prograf capsules dosing requiring conversion to once daily Advagraf should be converted on a 1:1(mg: mg) total daily dose basis.
harmonise the national SPCs of the medicinal product Prograf and associated names.
In stable patients converted from Prograf capsules(twice daily) to Advagraf(once daily) on a 1:1(mg: mg) total daily dose basis, the systemic exposure to tacrolimus(AUC0-24) for Advagraf was approximately 10% lower than that for Prograf.
The treatment difference(Envarsus- Prograf) was 0% 95% confidence interval -4.21%, 4.21.
This allows Advagraf to be given once a day, whereas Prograf/Prograft is given twice a day.
The percentages were 15% in the patients treated with Prograf/Prograft, and 17% in those treated with ciclosporin.
liver transplant patients showed that Advagraf and Prograf/ Prograft have comparable absorption in the body.
Because tacrolimus and Prograf/ Prograft have already been used in the EU,
The 12-month patient survival rates were 96.9% for Advagraf and 97.5% for Prograf; in the Advagraf arm 10 patients died(3 female, 7 male) and in the Prograf arm 8 patients died 3 female, 5 male.